Skip to main content

Day: May 2, 2024

Where Food Comes From, Inc. Reports 2024 First Quarter Financial Results

First Quarter Highlights – 2024 vs. 2023Verification and certification revenue up 17% to $4.4 million from $3.8 millionProduct sales lower at $0.7 million vs. $1.0 millionTotal revenue increased to $5.6 million from $5.3 millionNet income increased 47% to $178,000 from $121,000Diluted EPS increased to $0.03 from $0.02Adjusted EBITDA up 8% to $432,000 from $399,000Company bought back 116,072 shares of its common stock in Q1 at cost of $1.5 millionCASTLE ROCK, Colo., May 02, 2024 (GLOBE NEWSWIRE) — Where Food Comes From, Inc. (WFCF) (Nasdaq: WFCF), the most trusted resource for independent, third-party verification of food production practices in North America, today announced financial results for its first quarter ended March 31, 2024. “Despite the lingering impact of drought conditions resulting in smaller...

Continue reading

HomeTrust Bank Awarded Newsweek’s Most Loved Workplace Certification

ASHEVILLE, N.C., May 02, 2024 (GLOBE NEWSWIRE) — HomeTrust Bancshares, Inc. (NASDAQ: HTBI) (“Company”), the holding company of HomeTrust Bank (“Bank” or “HTB”), today announced that the Bank received a coveted Most Loved Workplace 2024 certification by Newsweek. Created in partnership with the Best Practices Institute, the annual ranking pays tribute to companies that put respect, caring and appreciation for employees at the center of their business model. “We are extremely proud to have HTB recognized by this distinguished certification,” said C. Hunter Westbrook, President & Chief Executive Officer. “Our team has intentionally worked on developing a behavioral-based culture that prioritizes two-way communication, a sense of belonging, opportunities for personal and professional growth, and benefits which support a strong...

Continue reading

Minera IRL Provides Bi-Weekly Default Status Report

LIMA, Peru, May 02, 2024 (GLOBE NEWSWIRE) — Minera IRL Limited (“Minera” or, the “Company”) (BVL:MIRL) (CSE:MIRL) (FWB:DZX) (OTCQB:MRLLF) is providing this default status report in accordance with National Policy 12-203 — Management Cease Trade Orders (“NP 12-203”) and the terms of a Management Cease Trade Order (“MCTO”) entered by the British Columbia Securities Commission (the “BCSC”) on April 3, 2024. The MCTO was entered against the Company’s Chief Executive Officer and its Interim Chief Financial Officer because the Company failed to file its annual audited financial statements, management’s discussion and analysis, annual information form and the required certifications (the “Annual Filings”) on or before April 2, 2024, as required by National Instrument 51-102, Continuous Disclosure Obligations, and National Instrument 52-109,...

Continue reading

Silvercrest Expands International and Global Equity Capability With Rehan Chaudhri, James A. Dunn, Jr., Ken Dennig, and Robert Gondolfo

NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) — Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) is pleased to announce the hiring of Rehan Chaudhri, James A. Dunn, Jr., Ken Dennig, and Robert Gondolfo to enhance the firm’s investment capabilities and global outreach. The team will expand upon Silvercrest’s comprehensive investment capabilities with their Global Equity Strategy, broadening the firm’s offerings to families and institutional investors. Richard Hough, Chairman and Chief Executive Officer of Silvercrest, remarked, “The team brings significant investment expertise, a proven track record, and experience managing equity mandates on behalf of large institutions around the world. Rehan and his team deepen the firm’s intellectual capital in the International and Global space and complement Silvercrest’s existing International...

Continue reading

Elis: General shareholders meeting 23 may 2024 – Availability of documents

General shareholders’ meeting to be held on May 23, 2024Availability of the documents relating to the general shareholders’ meeting Saint-Cloud, 2 May 2024 – The Combined General Shareholders’ Meeting of Elis will be held on May 23, 2024, at 3pm at the Maison des Travaux Publics, 3 rue de Berri, 75008 Paris. The General Meeting will be held in the physical presence of the shareholders; it will not be retransmitted on the company’s website. Holders of bearer shares should ask their financial intermediaries for proxy or distance voting forms. Holders of registered shares will directly receive these forms together with their convening notice. The corresponding notice of meeting that contains the agenda, the draft text of the resolutions to be submitted to the vote of the shareholders and the terms and conditions to participate and vote to...

Continue reading

Team Member Feedback Earns HealthEquity Workplace Culture Recognition

For the fourth consecutive year, team members’ feedback has propelled HealthEquity to be recognized for cultural excellence DRAPER, Utah, May 02, 2024 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest Health Savings Account (HSA) custodian has received a Culture Excellence Award by Top Workplaces for the fourth consecutive year. “Our teammates deserve all the credit when it comes to this award,” said Cheryl King, executive vice president and chief human resource officer. “They have embraced our values and strive to bring our mission to life each day. Together, we’re making big things happen. We know if we can create the best working environment for our teammates, we’ll create the best experience for our partners, clients, and members.” The Top Workplaces Culture Excellence Award utilizes...

Continue reading

Kforce Inc. Announces its Participation at the Baird 2024 Global Consumer, Technology and Services Conference

TAMPA, Fla., May 02, 2024 (GLOBE NEWSWIRE) — Kforce Inc. (NASDAQ: KFRC), a solutions firm that specializes in technology and professional staffing services, today announced that management will participate at Baird’s Global Consumer, Technology, and Services Conference on June 5, 2024, in New York City. A link to the webcast and presentation, which is currently scheduled for 4:20pm, can be accessed at www.kforce.com under “Events and Presentations.” A replay of the webcast will be available for three months following the presentation. About Kforce Inc.Kforce is a solutions firm specializing in technology, finance and accounting, and professional staffing services. Our KNOWLEDGEforce® empowers industry-leading companies to achieve their digital transformation goals. We curate teams of technical experts who build solutions custom-tailored...

Continue reading

Information on share capital and voting rights – April 2024

Information on share capital and voting rights April 2024 Statement made in accordance with article L. 233-8 II of the French commercial Code and articles 221-1 2 ° f) and 223-16 of the AMF Regulations.                          May 2nd, 2024   Statement made by:         Nexans S.A.Registered office : 4 Allée de l’Arche – 92400 CourbevoieRCS Nanterre 393 525 852Regulated market of Euronext Paris (Compartment A)Date   Total number of shares   Total number of voting rightsTheorical (1) Exercisable (2)April 30th, 2024 43,753,380 43,753,380 43,486,473(1)   Calculated based on all shares with voting rights, including treasury shares stripped of voting rights (Art. 223-11 of AMF General Regulations). (2)    For information, excluding treasury shares stripped of voting rights, excluding...

Continue reading

Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”) and Long-COVID (“LC”), announced today that it will report first quarter 2024 financial results on Thursday, May 9, 2024 before the open of the financial markets. Management will also host a webcast and conference call on May 9, 2024 at 8:30 a.m. ET to discuss the results and provide a corporate update. The live and archived webcast of the call may be accessed on the Virios Therapeutics website under the Investors section: Events and Presentations. The live call can be accessed by dialing 888-506-0062 (domestic) or 973-528-0011 (international) and asking to be connected to the...

Continue reading

Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

New role enhances company’s strong leadership team and solidifies commitment to ongoing clinical innovation DOYLESTOWN, Pa., May 02, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced the appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer (CMO) of the Company, effective May 1, 2024. Dr. Mirza has been an integral part of the Company’s senior team as a consultant since February, 2023 and will now assume a more central role in leading the Company’s development of its expanding clinical pipeline. “Aprea is at a critical point of enriching and expanding its clinical programs. Dr. Mirza has already made significant contributions to Aprea and we...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.